GENE ENCODING SHORT INTEGUMENTS AND USES THEREOF

Abstract: The present invention relates to the isolation and identification of a short integuments protein and the nucleic acid which encodes such proteins. The invention also relates to an expression vector containing the encoding nucleic acid and methods whereby plant fertility, fecundity and flowering time are increased or decreased by transformation of plants with that nucleic acid or variants thereof. The present invention also relates to transgenic cells, plants, and seeds containing the short integuments gene of the present invention.

Description: GENE ENCODING SHORT INTEGUMENTS AND USES THEREOF This application claims the benefit of U.S. Provisional Patent Application Serial No. 60/38,316, filed June 9, 1999. This invention was developed with government funding by the National Science Foundation, Grant No. IBN-9728239. The U.S. Government may have certain rights. FIELD OF THE INVENTION The invention relates to short integuments 1 nucleic acids and proteins, and to plants having altered phenotypes when transformed with short integuments 1 nucleic acids. BACKGROUND OF THE INVENTION According to recent estimates, the global demand for crop plants such as rice, wheat, and maize should increase by 40% by 2020. It is thought that classical plant breeding technology, which led to the green revolution in the late 1960s, will contribute less and less to meet this increasing demand, whereas plant genetic engineering will contribute increasingly more. An important thrust area in plant genetic engineering is the identification and use of genes implicated in asexual production of seeds, or "apomixis." Apomixis is thought to be an agronomically desirable trait that should enable seed companies and farmers to lock-in a favorable combination of genes for maximum grain yield without having to lose the gene combination in the next sexual generation. Genes for apomixis have not yet been identified. It is thought that genes that are generally important for very early embryo/seed development may be important for apomixis. A second important thrust is the production of early flowering varieties of plants such that breeding time can be reduced. The evolution of flowering plants may have entailed a modification of primitive leaf or leaf-like structures that contained naked ovules on their surfaces, to specify floral organs that ultimately evolved to surround the ovules (Herr, "The Origin of the Ovule," Am. J. Bot. 82:547-564 (1995); Stebbins, Flowering Plants: Evolution Above the Species Level. Cambridge, MA: Harvard University Press, pp. 199-245). This view of angiosperm evolution predicts that the genetic regulatory network that controls ovule development should be interlaced with that which triggers flowering. Ovule, as the precursor of seed, is the link to the next generation. Genetic regulatory pathways that are important for early vegetative development of the embryo inside the ovule, for late reproductive development leading to the production of ovules, and for morphogenesis of the haploid female gametophyte, are crucial areas of investigation which can lead to enhanced agricultural practices. Several genes important for ovule development have been identified in Arabidopsis thaliana (Reiser et al., "The Ovule and the Embryo Sac," The Plant Cell 5:1291-1301 (1993)). BELLI, a so-called cadastral gene that encodes a homeodomain protein (Reiser et al., "The BELLI Gene Encodes a Homeodomain Protein Involved in Pattern Formation in the Arabidopsis Ovule Primordium," Cell 83, 735-742 (1995)), controls the expression of the floral organ identity gene AG within the ovule and thereby controls morphogenesis of ovule integuments (Modrusan et al., "Homeotic Transformation of Ovules into Carpel- Like Structures in Arabidopsis 'X The Plant Cell 6:333-349 (1994); Ray et al., "The Arabidopsis Floral Homeotic Gene BELL (BELT) Controls Ovule Development Through Negative Regulation of AGAMOUS (AG) Gene," Proc. Natl. Acad. Sci. USA 91 :5761-5765 (1994)). SUPERMAN, another cadastral gene that restricts the spatial expression pattern of the floral organ identity gene AP3 (Sakai et al., "Role of SUPERMAN in Maintaining Arabidopsis Floral Whorl Boundaries," Nature 378:199-203 (1995)), is important in ovule integument development (Gaiser et al., "The Arabidopsis SUPERMAN Gene Mediates Asymmetric Growth of the Outer Integument of Ovules," The Plant Cell 7:333-345 (1995)). The organ identity gene AP2 is also known to control ovule morphogenesis (Modrusan et al., "Homeotic Transformation of Ovules into Carpel-Like Structures in Arabidopsis, ," The Plant Cell 6:333-349 (1994)). By contrast, no known meristem identity or flowering control gene had, until now, been demonstrated to have a role in ovule development. A gene termed SHORT INTEGUMENTS 1 (SIN1), genetically detected in the model plant Arabidopsis thaliana by mutational studies has been determined to be an important regulatory gene for plant reproductive development. The SIN1 gene is required for normal ovule development (Lang et al., "sinl, A Mutation Affecting Female Fertility in Arabidopsis, Interacts with modi, its Recessive Modifier," Genetics 137:1101-1110 (1994); Reiser et al., "The Ovule and the Embryo Sac," The Plant Cell 5:1291-1301 (1993); Robinson- Beers et al., "Ovule Development in Wild-Type Arabidopsis and Two Female Sterile Mutants," Plant Cell 4:1237-1250 (1992)). The original isolate of the sin] mutation (sinl-1 allele) was identified as one causing a female sterile phenotype (Robinson-Beers et al., "Ovule Development in Wild-Type Arabidopsis and Two Female Sterile Mutants," Plant Cell 4:1237-1250 (1992)). Ovules of the original isolate have short integuments and a defective megagametophyte (see Reiser et al., "The Ovule and the Embryo Sac," The Plant Cell 5:1291-1301 (1993)) for a review on ovule structure; Baker et al., "Interactions Among Genes Regulating Ovule Development in Arabidopsis thaliana," Genetics 145:1109-1124 (1997), for a recent genetic analysis; Schneitz et al., "Dissection of Sexual Organ Ontogenesis: A Genetic Analysis of Ovule Development in Arabidopsis thaliana," Development 124:1367-1376 (1997), for a summary of the known mutants affected in ovule development). It has been shown that the originally- described Sinl" mutant phenotype is a result of an interaction between sinl, and modi, its recessive modifier (Lang et al., "sinl, A Mutation Affecting Female Fertility in Arabidopsis, Interacts with modi, Its Recessive Modifier," Genetics 137:1101-1110 (1994)), and that modi is erecta, a mutation in a putative serine- threonine receptor protein kinase gene. The sinl-1 or sinl-2 mutation acting alone causes a defect in the coordination of growth of the two sheets of cells of the inner and outer integuments. All other originally described effects on the ovule, such as the lack of outer integument cell expansion and arrest of the megagametophyte, are due to secondary genetic interactions with erecta. There are several prospective protein phosphorylation sites within the SIΝ1 protein, and these might be substrates of protein kinases, such as the ERECTA product (Torii et al., "The Arabidopsis ERECTA Gene Encodes a Putative Protein Kinase with Extracellular Leucine-Rich Repeats," Plant Cell 8:735-746 (1996)). In plants homozygous for the weaker sinl-2 mutant allele, approximately 40% of all ovules in any flower mature into seeds. But these seeds frequently contain embryos arrested at different stages of development, some of which germinate to produce abnormal seedlings. Genetic analysis shows that the maternal expression of the SIN1 gene is necessary for embryo development (Ray et al., "Maternal Effects of the Short Integument Mutation on Embryo Development in Arabidopsis " Dev. Biol. 180:365-369 (1996)). Not only does this gene function in the formation of seeds, SZN/ is the only identified plant gene whose maternal expression is important for pattern formation in the zygotic embryo (Ray et al., "Maternal Effects of the Short Integument Mutation on Embryo Development in Arabidopsis," Dev. Biol. 180:365-369 (1996)). Both sinl-1 and sinl-2 alleles have the maternal-effect embryonic lethality phenotype (Ray et al., "Maternal Effects of the Short Integument Mutation on Embryo Development in Arabidopsis," Dev. Biol. 180:365-369 (1996)). The wild type S/N7 allele when transmitted through the pollen is unable to rescue the deleterious effects on embryogenesis of a homozygous maternal sinl-2 mutation. Ray et al. have shown that a wild type allele of SIN1 in the endosperm cannot rescue the maternal-effect of sinl-2 (Ray et al., "Maternal Effects of the Short Integument Mutation on Embryo Development in Arabidopsis," Dev. Biol. 180:365-369 (1996)). This is the first demonstration of a maternal effect embryonic pattern formation gene in a plant. In Arabidopsis thaliana, meristem development progresses through at least three distinct phases: from vegetative (V) through inflorescence (I) to the floral (F) mode, a process known as the "V - I -→- F switch." It has been shown that the sinl mutation causes a defect in the V -» I — » F switch. SINI is needed for the expression of the early flowering phenotype imparted by a TERMINAL FLOWERI (tfll) mutation, and tfll sinl double mutants do not produce pollen. Furthermore, sinl-1 allele enhances the effect of an APETALAJ (αpl) mutation. Thus, SINI represents a genetic connection between ovule development and control of flowering. In addition, the function of SINI gene is important for controlling the time to flower, another important agronomic factor because the timing of seed production depends on the flowering time. Ray et al. have shown by genetic analysis that SINI gene regulates the activity of a master switch gene, LEAFY (LFY) that controls flowering time in Arabidopsis thaliana. The LEAFY gene from Arabidopsis thaliana was shown to accelerate the flowering time of aspen (an economically important timber plant) from many years to a few months. Additionally, sinl mutants are late flowering (Ray et al., "SHORT INTEGUEMNT (sinl), A Gene Required For Ovule Development in Arabidopsis, Also Controls Flowering Time," Development 122, 2631-2638 (1996)) due to the production of an excess of vegetative leaves and lateral inflorescence axes before producing the floral primordia, which suggests a role of SINI in meristem fate determination. The ability to improve crop plant production through genetic engineering requires the identification and manipulation of previously unidentified genes that control developmentally important plant processes, including ovule development and flowering in plants. The present invention is directed to overcoming the deficiencies in the prior art. SUMMARY OF THE INVENTION The present invention relates to an isolated nucleic acid molecule encoding a short integuments 1 protein. The present invention also relates to an isolated short integuments 1 protein. The present invention also relates to a method of regulating flowering in plants that involves transducing a plant with a DNA molecule encoding a short integuments 1 protein under conditions effective to regulate flowering in the plant. The present invention also relates to a method of increasing fertility in plants that involves transducing a plant with a DNA molecule encoding a short integuments 1 protein under conditions effective to increase fertility. The present invention also relates to a method of increasing fecundity in plants that involves transducing a plant with a DNA molecule encoding a short integuments 1 protein under conditions effective to increase fecundity. The present invention also relates to a method of decreasing fertility in plants that involves transducing a plant with a DNA molecule encoding a short integuments 1 protein mutated to cause disruption of the DNA molecule under conditions effective to decrease fertility. The present invention also relates to an expression vector containing a DNA molecule encoding a short integumentsl protein, and plant cells, plant seeds and transgenic plants transformed with a DNA molecule encoding a short integumentsl protein. It is expected that elucidation of post-transcriptional regulation in plants will contribute significantly to the ability to control plant production through biotechnology. However, very little is currently understood about mechanisms of post-transcriptional controls, especially in plant reproduction. This invention overcomes this and other deficiencies in the art, as the SINI gene and its encoded protein, which play a vital role in fertility, seed production and flowering time control in plants, provide the agronomist with important tools for engineering the expression of genes involved in seed/embryo development and flowering time. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a map of the chromosomal region overlapping SINI and the functional domains of the predicted SINI protein. Figure 2 is a diagram of the BLAST derived homologies of the SINI protein. DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an isolated nucleic acid molecule encoding a short integumentsl (SINI) protein. One example of the nucleic acid molecule of the present invention is the SINI cDNA molecule, isolated from Arabidopsis thaliana, which has a nucleotide sequence corresponding to SEQ. ID. No. 1 as follows: gaagacgaag agagaaacag aacagagtag ggatcgatag accgtggaat ctcagaatca 60 caaacacttt gcaaaagggt tttcaattcc tatttattta caaagaaatc atcaatagta 120 gtggtctcta gggttttgct tgctcttctt cgtgacccct ttttacctgc aaacaacaac 180 ttcaaaattg gcgtgtttcg tacggtctat ctaaccctaa tctgtcacaa aacactcttc 240 ttctctcacc cctttttctg ggtttattca attctcgtgc ttttggttct gttttcttct 3 00 ctggggattt ggttttcttg agtgagtttt tctcctcttt cttatgttct tgatttgatt 360 attatataga attatggtaa tggaggatga gcctagagaa gccacaataa agccttctta 420 ttggctagat gcttgcgagg acatctcttg tgatcttatc gatgatctcg tgtctgaatt 480 tgatccttcc tctgttgctg tcaatgaatc cactgatgaa aacggcgtca tcaatgattt 540 tttcggtggg attgatcaca ttttagatag tatcaagaac ggtggaggct taccaaacaa 600 tggcgtttct gataccaatt ctcaaatcaa cgaggttact gtaactcctc aggttattgc 660 taaggagaca gtgaaggaga atgggttgca aaagaatggc ggtaagagag acgaattctc 720 gaaagaggaa ggagacaagg ataggaagag agctagggtt tgtagttatc agagtgaaag 780 gagtaacctt tcaggtagag ggcatgttaa taattctagg gagggagata ggtttatgaa 840 taggaaacgt actcgtaatt gggacgaggc gggtaacaat aagaagaaaa gggaatgtaa 900 caattacaga agagatggta gagatagaga agttaggggt tattgggaga gggataaagt 960 tggttccaat gagttggttt ataggtcagg gacttgggaa gctgatcatg aaagagatgt 1020 taagaaagtg agtggtggaa accgcgaatg cgatgtcaag gcagaggaga acaagagtaa 1080 gcctgaagaa cgtaaagaga aggttgtgga agagcaagca aggcgatacc agttggatgt 1140 tcttgaacaa gctaaagcga aaaacacgat tgctttcctt gagaccggtg ctggaaagac 1200 acttatcgcg attcttctta ttaaaagtgt tcataaggat ctgatgagcc agaacagaaa 1260 aatgctctcg gtgttcttgg ttcccaaagt gcctttggtt tatcagcaag cagaagtgat 1320 ccgtaatcaa acttgttttc aagttggaca ttattgtggt gagatgggac aggacttttg 1380 ggattctcga aggtggcaac gagagtttga gtctaagcag gttctagtta tgacagcaca 1440 aattctgttg aatatactga gacacagtat cattagaatg gaaacaattg atcttcttat 1500 tctcgacgag tgtcaccacg ctgtcaagaa acatccatac tctttagtga tgtcagagtt 1560 ttaccataca actcctaaag ataaaagacc tgccatcttt ggaatgactg cttcgcctgt 1620 taatttaaag ggtgtttcaa gccaagtaga ttgtgcgata aagatacgta acctcgagac 1680 caagttggat tctacggttt gtactataaa agatcgaaaa gaattagaga aacatgtgcc 1740 tatgccttca gagatagtcg tcgagtatga caaagctgct actatgtggt ctcttcatga 1800 gacaataaag caaatgattg cagctgttga agaagcggca caagcaagtt caaggaaaag 1860 caagtggcaa tttatggggg ctagggatgc tggagcaaag gatgaattga gacaggttta 1920 tggcgtctct gaaagaacgg agagcgatgg tgctgccaat ttgattcata aacttagagc 1980 tatcaattat actcttgctg aattgggtca atggtgtgct tacaaggtgg gacaatcatt 2040 cttgtctgct ttgcaaagtg atgagagggt gaatttccaa gtcgacgtga agtttcaaga 2100 atcatacctc agtgaggtgg tgtcactctt gcaatgtgag cttctggaag gcgctgctgc 2160 tgaaaaagtc gcggcggaag ttggcaaacc agaaaatggt aatgcacatg acgagatgga 2220 ggagggagag ctccctgatg atcctgtggt ctcgggaggg gagcacgttg atgaagtaat 2280 aggcgccgca gtggctgatg ggaaagttac tccaaaagta caatcattga tcaaactact 2340 cctcaaatat cagcacacag ctgattttcg agctattgtt ttcgttgaga gggtggttgc 2400 tgctttggtt cttcctaagg tttttgcgga gctgccttcg cttagtttta tacggtgtgc 2460 cagcatgatt ggacacaata acagccagga gatgaaatca tctcaaatgc aggatacaat 2520 ttccaaattc cgagatgggc atgtgacact gttagttgcc acaagcgttg ctgaggaagg 2580 acttgatatt aggcaatgta acgttgttat gcgtttcgac cttgcaaaga cggtgctggc 2640 atacattcag tctcgtggcc gggcaagaaa gcctggatca gactacatac tcatggttga 2700 gagaggaaat gtatctcacg cagcgttcct aaggaatgct aggaacagtg aggagacact 2760 tcgaaaagaa gcaatagaaa ggactgatct tagtcatctc aaagatacat cgagattaat 2820 ctcaattgat gctgtgcctg gtacagttta taaggtggag gcaactggtg ccatggttag 2880 cttgaattcc gcggttggtc ttgtacattt ctactgctct cagcttcctg gtgacaggta 2940 tgcaatcctt cgtcctgagt ttagcatgga gaagcatgaa aagcctgggg gccacacgga 3000 atattcatgt aggcttcagc ttccttgcaa tgcaccgttt gaaatacttg agggtcctgt 3060 ttgcagttca atgcgtcttg cacaacaggc tgtatgttta gctgcttgca agaaactgca 3120 tgagatgggt gcatttaccg atatgctatt accggacaaa ggaagtggtc aagacgctga 3180 gaaggctgac caagatgatg aaggtgagcc tgttcctgga actgctagac atagagagtt 3240 ctatcctgaa ggtgtggcgg atgtacttaa gggagaatgg gtttcatctg gaaaggaagt 3300 ttgtgagagc tcaaagctat tccatttata catgtataat gtcagatgtg tagattttgg 3360 ctcttcaaaa gatccattcc taagcgaagt ttcagagttc gcgattcttt ttggcaatga 3420 gctggatgca gaggtattat cgatgtctat ggatctttat gttgctcggg ccatgatcac 3480 taaagcatct cttgctttca agggatcact tgatattaca gaaaaccagc tatcatctct 3540 aaaaaagttt catgtgaggt taatgagtat cgtgttggat gttgatgttg aaccctccac 3600 gacaccatgg gatcctgcaa aggcctacct gtttgtccct gttactgaca atacgtctat 3660 ggaacccata aaagggatca actgggaatt ggttgaaaag attacgaaaa ccacagcgtg 3720 ggacaaccct cttcagagag ctcgtcccga tgtatatctc gggactaatg agagaactct 3780 tggtggggac agaagggaat atgggtttgg taaacttcgt cacaacattg tatttgggca 3840 gaaatctcac ccaacttatg gtattagagg agctgttgca tccttcgatg ttgtgagagc 3900 ttctggattg ttacctgtga gagatgcttt tgagaaggaa gtagaagagg atttatcaaa 3960 aggaaaattg atgatggctg atgggtgcat ggttgcagaa gatcttattg ggaaaatagt 4020 gacagccgca cattccggga agcggtttta cgtagattca atttgttatg acatgagtgc 4080 agaaacatct ttccctagga aagagggata tcttggtccc ctagagtaca acacgtacgc 4140 tgactattac aagcaaaagt atggagttga tttgaactgt aagcaacaac ctttgattaa 4200 aggacgtggt gtttcgtatt gcaagaacct tctttctcct cggtttgaac agtcaggtga 4260 atctgagaca gtccttgata agacatatta cgtgtttctt ccacctgaac tatgcgttgt 4320 gcatccgctt tcgggttcac ttatccgagg tgctcagagg ttaccctcta taatgagaag 4380 agttgagagc atgttactcg ctgttcaact caaaaatttg attagttatc ctattcccac 4440 atcaaagatt cttgaagcct tgactgccgc ctcgtgccag gaaacgttct gctacgagag 4500 agctgagctt ttaggagatg cgtatctaaa atgggttgtt agtcgttttc tgtttctcaa 4560 gtatcctcaa aagcacgagg gtcagcttac aaggatgagg caacaaatgg ttagtaatat 4620 ggttctttat cagtttgctc tggttaaagg gcttcagtca tatatccagg cggatcgatt 4680 cgccccgtct aggtggtctg ctcctggtgt gcctccggtt ttcgacgagg acacaaaaga 4740 tggaggatct tcgtttttcg atgaagagca aaaacctgtt tccgaggaaa acagcgatgt 4800 gtttgaagat ggggagatgg aggatggtga actagagggt gatttgagtt cgtaccgagt 4860 tttatctagc aaaacgttag ctgatgttgt tgaggctttg attggtgttt attacgtcga 4920 agggggtaag attgcagcta atcatttgat gaaatggatt gggattcacg tggaggatga 4980 tcctgatgaa gtcgatggaa cattgaaaaa tgttaatgtt ccagagagtg tgctcaagag 5040 catcgacttt gttggtcttg agagagctct taaatatgag tttaaagaga aaggtcttct 5100 tgttgaagct ataacacatg cttcaagacc atcttcaggt gtttcgtgtt accagagatt 5160 ggaatttgtt ggtgacgcgg tcttggatca tctcatcaca agacatctat ttttcacata 5220 cacaagcctt cctcctggtc ggttaacaga tcttcgagct gcagcggtta acaacgagaa 5280 ttttgctcgc gttgcggtta aacataaact ccacttgtac cttcgtcacg gttcaagcgc 5340 cctcgaaaaa cagattcggg aatttgtgaa ggaggttcaa accgagtcat cgaaaccggg 5400 gtttaactct tttggtttgg gagactgcaa agcaccaaaa gttcttggag acattgttga 5460 atctattgca ggtgctattt ttcttgatag tggaaaagat acaactgctg cttggaaggt 5520 ttttcaacct ttgcttcagc ccatggtgac accagagaca cttccaatgc atccggtgcg 5580 agagctacaa gagcggtgcc agcaacaagc agaagggtta gaatacaaag cgagtaggag 5640 tggtaacaca gcgactgtgg aagttttcat cgacggtgtt caagttggag tagcgcaaaa 5700 cccgcagaag aaaatggctc aaaagctagc tgcgaggaac gcacttgcag ctttgaaaga 5760 gaaagaaata gcagaatcaa aggagaagca tatcaacaac ggtaatgcgg gagaggatca 5820 aggcgagaat gagaatggga acaagaagaa tgggcatcag ccgtttacga gacaaacgtt 5880 gaatgatatt tgtttgagga agaattggcc aatgccttct tacagatgtg tgaaagaagg 5940 aggaccggct catgcaaaga gatttacgtt tggggtaaga gttaatacga gcgatagagg 6000 atggaccgat gagtgtattg gcgagccaat gccgagtgtt aagaaagcta aggattcagc 6060 tgcggttctt ctacttgagc ttttaaataa aactttttct tgattctttt actctcttca 6120 acgagatgta gtcattacat tttaaacctt aaaaccatag tggttgtagt gttttaaaaa 6180 aaaa 6184 The isolated cDNA has a 5727 bp open reading frame (ORF), a 374 bp 5 '-untranslated region (UTR), a 74 bp 3' -UTR and nine adenines at the 3'- end likely to be from the poly-A tail. The cDNA sequence confirmed the presence of 19 introns and 20 exons. A map of the chromosomal region overlapping SINI is shown in Figure 1. RS10, nga59, 12D7L and ACC2 are DNA sequence markers. Numbers within brackets are numbers of cross-overs between La-er and Columbia chromosomes. yUP20Dl and yUP12D7 are YAC clones; T4J2, T25K16 and F7I23 are BAC clones. The lower portion of the diagram shows intron-exon boundaries of SINI gene. The arrow above the susl-1 shows that site of insertion of the linked T-DNA in susl-1. That the open reading frame corresponds to S7N7 gene is substantiated by the findings that the susl, sinl-1, and sinl-2 mutant phenotypes are traceable to DΝA mutations in the SINI gene. The susl mutation is due to DΝA insertion within the 5 th exon of the S7N7 gene. The sinl-1 and sinl-2 phenotypes are the result of single-base pair changes, in exon 3 and exon 4, respectively. A single C to T transition in sinl-1 and a T to A transversion in sinl-2 reading frames were detected. Also suitable as an isolated nucleic acid molecule according to the present invention is a nucleic acid which has a nucleotide sequence that is at least 55% similar to the nucleotide sequence of SEQ. ID. No. 1 by basic BLAST using default parameters analysis. Also suitable as an isolated nucleic acid molecule according to the present invention is an isolated nucleic acid molecule encoding a short integumentsl protein, wherein the nucleic acid hybridizes to the nucleotide sequence of SEQ. ID. No. 1 under stringent conditions characterized by a hybridization buffer comprising 0.9M sodium citrate buffer at a temperature of 45°C. The nucleotide sequence of SEQ. ID. NO. 1 encodes a protein having an amino acid sequence corresponding to SEQ. ID. No. 2. as follows: Met Val Met Glu Asp Glu Pro Arg Glu Ala Thr lie Lys Pro Ser Tyr 1 5 10 15 Trp Leu Asp Ala Cys Glu Asp lie Ser Cys Asp Leu lie Asp Asp Leu 20 25 30 Val Ser Glu Phe Asp Pro Ser Ser Val Ala Val Asn Glu Ser Thr Asp 35 40 45 Glu Asn Gly Val lie Asn Asp Phe Phe Gly Gly lie Asp His lie Leu 50 55 60 Asp Ser lie Lys Asn Gly Gly Gly Leu Pro Asn Asn Gly Val Ser Asp 65 70 75 80 Thr Asn Ser Gin lie Asn Glu Val Thr Val Thr Pro Gin Val lie Ala 85 90 95 Lys Glu Thr Val Lys Glu Asn Gly Leu Gin Lys Asn Gly Gly Lys Arg 100 105 110 Asp Glu Phe Ser Lys Glu Glu Gly Asp Lys Asp Arg Lys Arg Ala Arg 115 120 125 Val Cys Ser Tyr Gin Ser Glu Arg Ser Asn Leu Ser Gly Arg Gly His 130 135 140 Val Asn Asn Ser Arg Glu Gly Asp Arg Phe Met Asn Arg Lys Arg Thr 145 150 155 160 Arg Asn Trp Asp Glu Ala Gly Asn Asn Lys Lys Lys Arg Glu Cys Asn 165 170 175 Asn Tyr Arg Arg Asp Gly Arg Asp Arg Glu Val Arg Gly Tyr Trp Glu 180 185 190 Arg Asp Lys Val Gly Ser Asn Glu Leu Val Tyr Arg Ser Gly Thr Trp 195 200 205 Glu Ala Asp His Glu Arg Asp Val Lys Lys Val Ser Gly Gly Asn Arg 210 215 220 Glu Cys Asp Val Lys Ala Glu Glu Asn Lys Ser Lys Pro Glu Glu Arg 225 230 235 240 Lys Glu Lys Val Val Glu Glu Gin Ala Arg Arg Tyr Gin Leu Asp Val 245 250 255 Leu Glu Gin Ala Lys Ala Lys Asn Thr lie Ala Phe Leu Glu Thr Gly 260 265 270 Ala Gly Lys Thr Leu lie Ala lie Leu Leu lie Lys Ser Val His Lys 275 280 285 Asp Leu Met Ser Gin Asn Arg Lys Met Leu Ser Val Phe Leu Val Pro 290 295 300 Lys Val Pro Leu Val Tyr Gin Gin Ala Glu Val lie Arg Asn Gin Thr 305 310 315 320 Cys Phe Gin Val Gly His Tyr Cys Gly Glu Met Gly Gin Asp Phe Trp 325 330 335 Asp Ser Arg Arg Trp Gin Arg Glu Phe Glu Ser Lys Gin Val Leu Val 340 345 350 Met Thr Ala Gin lie Leu Leu Asn lie Leu Arg His Ser lie lie Arg 355 360 365 Met Glu Thr lie Asp Leu Leu lie Leu Asp Glu Cys His His Ala Val 370 375 380 Lys Lys His Pro Tyr Ser Leu Val Met Ser Glu Phe Tyr His Thr Thr 385 390 395 400 Pro Lys Asp Lys Arg Pro Ala lie Phe Gly Met Thr Ala Ser Pro Val 405 410 415 Asn Leu Lys Gly Val Ser Ser Gin Val Asp Cys Ala lie Lys lie Arg 420 425 430 Asn Leu Glu Thr Lys Leu Asp Ser Thr Val Cys Thr lie Lys Asp Arg 435 440 445 Lys Glu Leu Glu Lys His Val Pro Met Pro Ser Glu lie Val Val Glu 450 455 460 Tyr Asp Lys Ala Ala Thr Met Trp Ser Leu His Glu Thr lie Lys Gin 465 470 475 480 Met lie Ala Ala Val Glu Glu Ala Ala Gin Ala Ser Ser Arg Lys Ser 485 490 495 Lys Trp Gin Phe Met Gly Ala Arg Asp Ala Gly Ala Lys Asp Glu Leu 500 505 510 Arg Gin Val Tyr Gly Val Ser Glu Arg Thr Glu Ser Asp Gly Ala Ala 515 520 525 Asn Leu lie His Lys Leu Arg Ala lie Asn Tyr Thr Leu Ala Glu Leu 530 535 540 Gly Gin Trp Cys Ala Tyr Lys Val Gly Gin Ser Phe Leu Ser Ala Leu 545 550 555 560 Gin Ser Asp Glu Arg Val Asn Phe Gin Val Asp Val Lys Phe Gin Glu 565 570 575 Ser Tyr Leu Ser Glu Val Val Ser Leu Leu Gin Cys Glu Leu Leu Glu 580 585 590 Gly Ala Ala Ala Glu Lys Val Ala Ala Glu Val Gly Lys Pro Glu Asn 595 600 605 Gly Asn Ala His Asp Glu Met Glu Glu Gly Glu Leu Pro Asp Asp Pro 610 615 620 Val Val Ser Gly Gly Glu His Val Asp Glu Val lie Gly Ala Ala Val 625 630 635 640 Ala Asp Gly Lys Val Thr Pro Lys Val Gin Ser Leu lie Lys Leu Leu 645 650 655 Leu Lys Tyr Gin His Thr Ala Asp Phe Arg Ala lie Val Phe Val Glu 660 665 670 Arg Val Val Ala Ala Leu Val Leu Pro Lys Val Phe Ala Glu Leu Pro 675 680 685 Ser Leu Ser Phe lie Arg Cys Ala Ser Met lie Gly His Asn Asn Ser 690 695 700 Gin Glu Met Lys Ser Ser Gin Met Gin Asp Thr lie Ser Lys Phe Arg 705 710 715 720 Asp Gly His Val Thr Leu Leu Val Ala Thr Ser Val Ala Glu Glu Gly 725 730 735 Leu Asp lie Arg Gin Cys Asn Val Val Met Arg Phe Asp Leu Ala Lys 740 745 ^ 750 Thr Val Leu Ala Tyr lie Gin Ser Arg Gly Arg Ala Arg Lys Pro Gly 755 760 765 Ser Asp Tyr He Leu Met Val Glu Arg Gly Asn Val Ser His Ala Ala 770 775 780 Phe Leu Arg Asn Ala Arg Asn Ser Glu Glu Thr Leu Arg Lys Glu Ala 785 790 795 800 He Glu Arg Thr Asp Leu Ser His Leu Lys Asp Thr Ser Arg Leu He 805 810 815 Ser He Asp Ala Val Pro Gly Thr Val Tyr Lys Val Glu Ala Thr Gly 820 825 830 Ala Met Val Ser Leu Asn Ser Ala Val Gly Leu Val His Phe Tyr Cys 835 840 845 Ser Gin Leu Pro Gly Asp Arg Tyr Ala He Leu Arg Pro Glu Phe Ser 850 855 860 Met Glu Lys His Glu Lys Pro Gly Gly His Thr Glu Tyr Ser Cys Arg 865 870 875 880 Leu Gin Leu Pro Cys Asn Ala Pro Phe Glu He Leu Glu Gly Pro Val 885 890 895 Cys Ser Ser Met Arg Leu Ala Gin Gin Ala Val Cys Leu Ala Ala Cys 900 905 910 Lys Lys Leu His Glu Met Gly Ala Phe Thr Asp Met Leu Leu Pro Asp 915 920 925 Lys Gly Ser Gly Gin Asp Ala Glu Lys Ala Asp Gin Asp Asp Glu Gly 930 935 940 Glu Pro Val Pro Gly Thr Ala Arg His Arg Glu Phe Tyr Pro Glu Gly 945 950 955 960 Val Ala Asp Val Leu Lys Gly Glu Trp Val Ser Ser Gly Lys Glu Val 965 970 975 Cys Glu Ser Ser Lys Leu Phe His Leu Tyr Met Tyr Asn Val Arg Cys 980 985 990 Val Asp Phe Gly Ser Ser Lys Asp Pro Phe Leu Ser Glu Val Ser Glu 995 1000 1005 Phe Ala He Leu Phe Gly Asn Glu Leu Asp Ala Glu Val Leu Ser Met 1010 1015 1020 Ser Met Asp Leu Tyr Val Ala Arg Ala Met He Thr Lys Ala Ser Leu 1025 1030 1035 1040 Ala Phe Lys Gly Ser Leu Asp He Thr Glu Asn Gin Leu Ser Ser Leu 1045 1050 1055 Lys Lys Phe His Val Arg Leu Met Ser He Val Leu Asp Val Asp Val 1060 1065 1070 Glu Pro Ser Thr Thr Pro Trp Asp Pro Ala Lys Ala Tyr Leu Phe Val 1075 1080 1085 Pro Val Thr Asp Asn Thr Ser Met Glu Pro He Lys Gly He Asn Trp 1090 1095 1100 Glu Leu Val Glu Lys He Thr Lys Thr Thr Ala Trp Asp Asn Pro Leu 1105 1110 1115 1120 Gin Arg Ala Arg Pro Asp Val Tyr Leu Gly Thr Asn Glu Arg Thr Leu 1125 1130 1135 Gly Gly Asp Arg Arg Glu Tyr Gly Phe Gly Lys Leu Arg His Asn He 1140 1145 1150 Val Phe Gly Gin Lys Ser His Pro Thr Tyr Gly He Arg Gly Ala Val 1155 1160 1165 Ala Ser Phe Asp Val Val Arg Ala Ser Gly Leu Leu Pro Val Arg Asp 1170 1175 1180 Ala Phe Glu Lys Glu Val Glu Glu Asp Leu Ser Lys Gly Lys Leu Met 1185 1190 1195 1200 Met Ala Asp Gly Cys Met Val Ala Glu Asp Leu He Gly Lys He Val 1205 1210 1215 Thr Ala Ala His Ser Gly Lys Arg Phe Tyr Val Asp Ser He Cys Tyr 1220 1225 1230 Asp Met Ser Ala Glu Thr Ser Phe Pro Arg Lys Glu Gly Tyr Leu Gly 1235 1240 1245 Pro Leu Glu Tyr Asn Thr Tyr Ala Asp Tyr Tyr Lys Gin Lys Tyr Gly 1250 1255 1260 Val Asp Leu Asn Cys Lys Gin Gin Pro Leu He Lys Gly Arg Gly Val 1265 1270 1275 1280 Ser Tyr Cys Lys Asn Leu Leu Ser Pro Arg Phe Glu Gin Ser Gly Glu 1285 1290 1295 Ser Glu Thr Val Leu Asp Lys Thr Tyr Tyr Val Phe Leu Pro Pro Glu 1300 1305 1310 Leu Cys Val Val His Pro Leu Ser Gly Ser Leu He Arg Gly Ala Gin 1315 1320 1325 Arg Leu Pro Ser He Met Arg Arg Val Glu Ser Met Leu Leu Ala Val 1330 1335 1340 Gin Leu Lys Asn Leu He Ser Tyr Pro He Pro Thr Ser Lys He Leu 1345 1350 1355 1360 Glu Ala Leu Thr Ala Ala Ser Cys Gin Glu Thr Phe Cys Tyr Glu Arg 1365 1370 1375 Ala Glu Leu Leu Gly Asp Ala Tyr Leu Lys Trp Val Val Ser Arg Phe 1380 1385 1390 Leu Phe Leu Lys Tyr Pro Gin Lys His Glu Gly Gin Leu Thr Arg Met 1395 1400 1405 Arg Gin Gin Met Val Ser Asn Met Val Leu Tyr Gin Phe Ala Leu Val 1410 1415 1420 Lys Gly Leu Gin Ser Tyr He Gin Ala Asp Arg Phe Ala Pro Ser Arg 1425 1430 1435 1440 Trp Ser Ala Pro Gly Val Pro Pro Val Phe Asp Glu Asp Thr Lys Asp 1445 1450 1455 Gly Gly Ser Ser Phe Phe Asp Glu Glu Gin Lys Pro Val Ser Glu Glu 1460 1465 1470 Asn Ser Asp Val Phe Glu Asp Gly Glu Met Glu Asp Gly Glu Leu Glu 1475 1480 1485 Gly Asp Leu Ser Ser Tyr Arg Val Leu Ser Ser Lys Thr Leu Ala Asp 1490 1495 1500 Val Val Glu Ala Leu He Gly Val Tyr Tyr Val Glu Gly Gly Lys He 1505 1510 1515 1520 Ala Ala Asn His Leu Met Lys Trp He Gly He His Val Glu Asp Asp 1525 1530 1535 Pro Asp Glu Val Asp Gly Thr Leu Lys Asn Val Asn Val Pro Glu Ser 1540 1545 1550 Val Leu Lys Ser He Asp Phe Val Gly Leu Glu Arg Ala Leu Lys Tyr 1555 1560 1565 Glu Phe Lys Glu Lys Gly Leu Leu Val Glu Ala He Thr H s Ala Ser 1570 1575 1580 Arg Pro Ser Ser Gly Val Ser Cys Tyr Gin Arg Leu Glu Phe Val Gly 1585 1590 1595 1600 Asp Ala Val Leu Asp His Leu He Thr Arg His Leu Phe Phe Thr Tyr 1605 1610 1615 Thr Ser Leu Pro Pro Gly Arg Leu Thr Asp Leu Arg Ala Ala Ala Val 1620 1625 1630 Asn Asn Glu Asn Phe Ala Arg Val Ala Val Lys His Lys Leu His Leu 1635 1640 1645 Tyr Leu Arg His Gly Ser Ser Ala Leu Glu Lys Gin He Arg Glu Phe 1650 1655 1660 Val Lys Glu Val Gin Thr Glu Ser Ser Lys Pro Gly Phe Asn Ser Phe 1665 1670 1675 1680 Gly Leu Gly Asp Cys Lys Ala Pro Lys Val Leu Gly Asp He Val Glu 1685 1690 1695 Ser He Ala Gly Ala He Phe Leu Asp Ser Gly Lys Asp Thr Thr Ala 1700 1705 1710 Ala Trp Lys Val Phe Gin Pro Leu Leu Gin Pro Met Val Thr Pro Glu 1715 1720 1725 Thr Leu Pro Met His Pro Val Arg Glu Leu Gin Glu Arg Cys Gin Gin 1730 1735 1740 Gin Ala Glu Gly Leu Glu Tyr Lys Ala Ser Arg Ser Gly Asn Thr Ala 1745 1750 1755 1760 Thr Val Glu Val Phe He Asp Gly Val Gin Val Gly Val Ala Gin Asn 1765 1770 1775 Pro Gin Lys Lys Met Ala Gin Lys Leu Ala Ala Arg Asn Ala Leu Ala 1780 1785 1790 Ala Leu Lys Glu Lys Glu He Ala Glu Ser Lys Glu Lys His He Asn 1795 1800 1805 Asn Gly Asn Ala Gly Glu Asp Gin Gly Glu Asn Glu Asn Gly Asn Lys 1810 1815 1820 Lys Asn Gly His Gin Pro Phe Thr Arg Gin Thr Leu Asn Asp He Cys 1825 1830 1835 1840 Leu Arg Lys Asn Trp Pro Met Pro Ser Tyr Arg Cys Val Lys Glu Gly 1845 1850 1855 Gly Pro Ala His Ala Lys Arg Phe Thr Phe Gly Val Arg Val Asn Thr 1860 1865 1870 Ser Asp Arg Gly Trp Thr Asp Glu Cys He Gly Glu Pro Met Pro Ser 1875 1880 1885 Val Lys Lys Ala Lys Asp Ser Ala Ala Val Leu Leu Leu Glu Leu Leu 1890 1895 1900 Asn Lys Thr Phe Ser 1905 Analysis of this protein revealed a domain structure highly suggestive of an RNA helicase (Company et al.. "Requirement of the RNA Helicase-Like Protein PRP22 for Release of Messenger RNA from Spliceosomes," Nature 349:487-493 (1991); Linder et al., "Birth of the D-E-A-D Box," Nature 337:121-122 (1989); Luking et al., " The Protein Family of RNA Helicases," Grit. Rev. Biochem. Mol. Biol. 33:259-296 (1998); Martins et al., "Mutational Analysis of Vaccinia Virus Nucleoside Triphosphate Phosphohydrolase I, a DNA-Dependent ATPase of the DExH Box Family," Journal of Virology 73:1302-1308 (1999), which are hereby incorporated by reference), of which Drosophila maternal effect gene Vasa is a representative (Rongo et al., "Germplasm Assembly and Germ Cell Migration in Drosophila," Cold Spring Harb. Svmp. Quant. Biol. 62 : 1 - 1 1 ( 1997), which is hereby incorporated by reference). Shown in the lower portion of Figure 1 is the arrangement of functional motifs of the predicted SINI protein: a bipartite N- terminal nuclear localization signal (NLS), an RNA helicase C domain, two RNase III catalytic domains, a PIMS (for PIWI Middle domain-SHORT INTEGUMENTS 1 , PIWI being a family of important plant developmental proteins) motif, and two C-terminal repeats of a dsRNA binding domain. A BLAST search yielded numerous high homology strikes of these domains, as shown in Figure 2. Each of the three functional domains is strongly conserved within its own family. For example, the helicase C motif shows strong similarity, among others, to yeast RRP3, DRSl and fly Vasa products, RNase3 domains to pombe PAC1 or worm K12H4.8 (YM68), and dsRBD domains to Drosophila Staufen products. Fragments of the above protein are also encompassed by the present invention. Suitable fragments can be produced by several means. In the first, subclones of the gene encoding the protein of the present invention are produced by conventional molecular genetic manipulation by subcloning gene fragments. The subclones then are expressed in vitro or in vivo in bacterial cells to yield a smaller protein or peptide. In another approach, based on knowledge of the primary structure of the protein of the present invention, fragments of the gene of the present invention may be synthesized by using the PCR technique together with specific sets of primers chosen to represent particular portions of the protein. These then would be cloned into an appropriate vector for increased expression of an accessory peptide or protein. Chemical synthesis can also be used to make suitable fragments. Such a synthesis is carried out using known amino acid sequences for the protein of the present invention. These fragments can then be separated by conventional procedures (e.g., chromatography, SDS-PAGE) and used in the methods of the present invention. Variants may also (or alternatively) be prepared by, for example, the deletion or addition of amino acids that have minimal influence on the properties, secondary structure, and hydropathic nature of the polypeptide. For example, a polypeptide may be conjugated to a signal (or leader) sequence at the N-terminal end of the protein which co-translationally or post-translationally directs transfer of the protein. The polypeptide may also be conjugated to a linker or other sequence for ease of synthesis, purification, or identification of the polypeptide. The present invention also relates to an expression vector containing a DNA molecule encoding a short integumentsl protein. The nucleic acid molecule of the present invention may be inserted into any of the many available expression vectors and cell systems using reagents that are well known in the art. In preparing a DNA vector for expression, the various DNA sequences may normally be inserted or substituted into a bacterial plasmid. Any convenient plasmid may be employed, which will be characterized by having a bacterial replication system, a marker which allows for selection in a bacterium and generally one or more unique, conveniently located restriction sites. Numerous plasmids, referred to as transformation vectors, are available for plant transformation. The selection of a vector will depend on the preferred transformation technique and target species for transformation. A variety of vectors are available for stable transformation using Agrobacterium tumefaciens, a soilborne bacterium that causes crown gall. Crown gall are characterized by tumors or galls that develop on the lower stem and main roots of the infected plant. These tumors are due to the transfer and incorporation of part of the bacterium plasmid DNA into the plant chromosomal DNA. This transfer DNA (T-DNA) is expressed along with the normal genes of the plant cell. The plasmid DNA, pTI, or Ti-DNA. for "tumor inducing plasmid," contains the vir genes necessary for movement of the T-DNA into the plant. The T-DNA carries genes that encode proteins involved in the biosynthesis of plant regulatory factors, and bacterial nutrients (opines). The T-DNA is delimited by two 25 bp imperfect direct repeat sequences called the "border sequences." By removing the oncogene and opine genes, and replacing them with a gene of interest, it is possible to transfer foreign DNA into the plant without the formation of tumors or the multiplication of Agrobacterium tumefaciens. Fraley, et al., "Expression of Bacterial Genes in Plant Cells," Proc. Nat'l Acad. Sci.. 80:4803-4807 (1983). which is hereby incorporated by reference. Further improvement of this technique led to the development of the binary vector system. Bevan, M., "Binary Agrobacterium Vectors for Plant Transformation," Nucleic Acids Res. 12:8711-8721 (1984), which is hereby incorporated by reference. In this system, all the T-DNA sequences (including the borders) are removed from the pTi, and a second vector containing T-DNA is introduced into Agrobacterium tumefaciens. This second vector has the advantage of being replicable in E. coli as well as A. tumefaciens, and contains a multiclonal site that facilitates the cloning of a transgene. An example of a commonly used vector is pBinl9. Frisch, et al., "Complete Sequence of the Binary Vector Binl9," Plant Molec. Biol. 27:405-409 (1995), which is hereby incorporated by reference. Any appropriate vectors now known or later described for genetic transformation are suitable for use with the present invention. U.S. Patent No. 4,237,224 issued to Cohen and Boyer, which is hereby incorporated by reference, describes the production of expression systems in the form of recombinant plasmids using restriction enzyme cleavage and ligation with DNA ligase. These recombinant plasmids are then introduced by means of transformation and replicated in unicellular cultures including procaryotic organisms and eucaryotic cells grown in tissue culture. In one aspect of the present invention, the nucleic acid molecule of the present invention is incorporated into an appropriate vector in the sense direction, such that the open reading frame is properly oriented for the expression of the encoded protein under control of a promoter of choice. Certain "control elements" or "regulatory sequences" are also incorporated into the vector-construct. Those non-translated regions of the vector, promoters, 5' and 3' untranslated regions- which interact with host cellular proteins to carry out transcription and translation. Such elements may vary in their strength and specificity. Depending on the vector system and host utilized, any number of suitable transcription and translation elements, including constitutive and inducible promoters, may be used. A constitutive promoter is a promoter that directs expression of a gene throughout the development and life of an organism. Examples of some constitutive promoters that are widely used for inducing expression of transgenes include the nopoline synthase (NOS) gene promoter, from Agrobacterium tumefaciens, (U.S. Patent 5034322 to Rogers et al., which is hereby incorporated by reference), the cauliflower mosaic virus (CaMv) 35S and 19S promoters (U.S. Patent No. 5,352,605 to Fraley et al., which is hereby incorporated by reference), those derived from any of the several actin genes, which are known to be expressed in most cells types (U.S. Patent No. 6,002,068 to Privalle et al., which is hereby incorporated by reference), and the ubiquitin promoter, which is a gene product known to accumulate in many cell types. An inducible promoter is a promoter that is capable of directly or indirectly activating transcription of one or more DNA sequences or genes in response to an inducer. In the absence of an inducer, the DNA sequences or genes will not be transcribed. The inducer can be a chemical agent, such as a metabolite, growth regulator, herbicide or phenolic compound, or a physiological stress directly imposed upon the plant such as cold, heat, salt, toxins, or through the action of a pathogen or disease agent such as a virus or fungus. A plant cell containing an inducible promoter may be exposed to an inducer by externally applying the inducer to the cell or plant such as by spraying, watering, heating, or by exposure to the operative pathogen. An example of an appropriate inducible promoter for use in the present invention is a glucocorticoid-inducible promoter (Schena et al.. " A Steroid-Inducible Gene Expression System for Plant Cells," Proc. Natl. Acad. Sci. 88:10421-5 (1991), which is hereby incorporated by reference). Expression of the SINI protein is induced in the plants transformed with the S7N7 gene when the transgenic plants are brought into contact with nanomolar concentrations of a glucocorticoid, or by contact with dexamethasone, a glucocorticoid analog. Schena et al.. " A Steroid-Inducible Gene Expression System for Plant Cells." Proc. Νatl. Acad. Sci. USA 88:10421-5 (1991); Aoyama et al., "A Glucocorticoid-Mediated Transcriptional Induction System in Transgenic Plants," Plant J. 11 : 605-612 (1997), and McΝellis et al., "Glucocorticoid-Inducible Expression of a Bacterial Avirulence Gene in Transgenic Arabidopsis Induces Hypersensitive Cell Death, Plant J. 14(2):247-57 (1998), which are hereby incorporated by reference. In addition, inducible promoters include promoters that function in a tissue specific manner to regulate the gene of interest within selected tissues of the plant. Examples of such tissue specific promoters include seed, flower, or root specific promoters as are well known in the field (U.S. Patent No. 5,750,385 to Shewmaker et al., which is hereby incorporated by reference). The DNA construct of the present invention also includes an operable 3' regulatory region, selected from among those which are capable of providing correct transcription termination and polyadenylation of mRNA for expression in the host cell of choice, operably linked to a DNA molecule which encodes for a protein of choice. A number of 3' regulatory regions are known to be operable in plants. Exemplary 3' regulatory regions include, without limitation, the nopaline synthase 3' regulatory region (Fraley, et al., "Expression of Bacterial Genes in Plant Cells," Proc. Nat'l Acad. Sci. USA 80:4803-4807 (1983), which is hereby incorporated by reference) and the cauliflower mosaic virus 3' regulatory region (Odell, et al., "Identification of DNA Sequences Required for Activity of the Cauliflower Mosaic Virus 35S Promoter," Nature 313(6005):810-812 (1985), which is hereby incorporated by reference). Virtually any 3' regulatory region known to be operable in plants would suffice for proper expression of the coding sequence of the DNA construct of the present invention. The vector of choice, promoter, and an appropriate 3' regulatory region can be ligated together to produce the plasmid of the present invention using well known molecular cloning techniques as described in Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor Press, NY (1989), and Ausubel, F. M. et al. (1989) Current Protocols in Molecular Biology, John Wiley & Sons, New York, N.Y., which are hereby incorporated by reference. Once the DNA construct of the present invention has been prepared, it is ready to be incorporated into a host cell. Recombinant molecules can be introduced into cells via transformation, particularly transduction, conjugation, mobilization, or electroporation. The DNA sequences are cloned into the host cell using standard cloning procedures known in the art, as described by Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition, Cold Springs Laboratory, Cold Springs Harbor, New York (1989), which is hereby incorporated by reference. Suitable host cells include, but are not limited to, bacteria, virus, yeast, mammalian cells, insect, plant, and the like. Preferably the host cells are either a bacterial cell or a plant cell. Accordingly, another aspect of the present invention relates to a method of making a recombinant cell. Basically, this method is carried out by transforming a plant cell with a DNA construct of the present invention under conditions effective to yield transcription of the DNA molecule in the plant cell. Preferably, the DNA construct of the present invention is stably inserted into the genome of the recombinant plant cell as a result of the transformation. One approach to transforming plant cells with a DNA construct of the present invention is particle bombardment (also known as biolistic transformation) of the host cell. This can be accomplished in one of several ways. The first involves propelling inert or biologically active particles at cells. This technique is disclosed in U.S. Patent Nos. 4,945,050, 5,036,006, and 5,100,792, all to Sanford, et al., which are hereby incorporated by reference. Generally, this procedure involves propelling inert or biologically active particles at the cells under conditions effective to penetrate the outer surface of the cell and to be incorporated within the interior thereof. When inert particles are utilized, the vector can be introduced into the cell by coating the particles with the vector containing the heterologous DNA. Alternatively, the target cell can be surrounded by the vector so that the vector is carried into the cell by the wake of the particle. Biologically active particles (e.g., dried bacterial cells containing the vector and heterologous DNA) can also be propelled into plant cells. Other variations of particle bombardment, now known or hereafter developed, can also be used. Transient expression in protoplasts allows quantitative studies of gene expression since the population of cells is very high (on the order of 10 ). To deliver DNA inside protoplasts, several methodologies have been proposed, but the most common are electroporation (Fromm et al., "Expression of Genes Transferred Into Monocot and Dicot Plants by Electroporation," Proc. Natl. Acad. Sci. USA 82:5824-5828 (1985), which is hereby incorporated by reference) and polyethylene glycol (PEG) mediated DNA uptake (Krens et al., "In Vitro Transformation of Plant Protoplasts with Ti-Plasmid DNA," Nature 296:72-74 (1982), which is hereby incorporated by reference). During electroporation, the DNA is introduced into the cell by means of a reversible change in the permeability of the cell membrane due to exposure to an electric field. PEG transformation introduces the DNA by changing the elasticity of the membranes. Unlike electroporation, PEG transformation does not require any special equipment and transformation efficiencies can be equally high. Another appropriate method of introducing the gene construct of the present invention into a host cell is fusion of protoplasts with other entities, either minicells, cells, lysosomes, or other fusible lipid-surfaced bodies that contain the chimeric gene. Fraley, et al., Proc. Natl. Acad. Sci. USA, 79:1859-63 (1982), which is hereby incorporated by reference. Stable transformants are preferable for the methods of the present invention. An appropriate method of stably introducing the DNA construct into plant cells is to infect a plant cell with Agrobacterium tumefaciens or Agrobacterium rhizogenes previously transformed with the DNA construct. Under appropriate conditions known in the art, the transformed plant cells are grown to form shoots or roots, and develop further into plants. In one embodiment of the present invention stable transformants are generated using Agrobacterium using the "dipping" method, a modification of the vacuum infiltration method as described in Bent et al., "Floral Dip: A Simplified Method for Agrobacterium-Mediated Transformation of Arabidopsis thaliana," Plant J. 16:735-43 (1998), which is hereby incorporated by reference. Plant tissues suitable for transformation include, but are not limited to, floral buds, leaf tissue, root tissue, meristems, zygotic and somatic embryos, megaspores, and anthers. After transformation, the transformed plant cells can be selected and regenerated. Preferably, transformed cells are first identified using a selection marker simultaneously introduced into the host cells along with the DNA construct of the present invention. The most widely used reporter gene for gene fusion experiments has been uidA, a gene from Escherichia coli that encodes the β-glucuronidase protein, also known as GUS. Jefferson et al., "GUS Fusions: β Glucuronidase as a Sensitive and Versatile Gene Fusion Marker in Higher Plants," EMBO Journal 6:3901-3907 (1987), which is hereby incorporated by reference. GUS is a 68.2 kd protein that acts as a tetramer in its native form. It does not require cofactors or special ionic conditions, although it can be inhibited by divalent cations like Cu + or Zn + . GUS is active in the presence of thiol reducing agents like β-mercaptoethanol or dithiothreitol (DTT). In order to evaluate GUS activity, several substrates are available. The most commonly used are 5 bromo-4 chloro-3 indolyl glucuronide (X-Gluc) and 4 methyl-umbelliferyl-glucuronide (MUG). The reaction with X-Gluc generates a blue color that is useful in histochemical detection of the gene activity. For quantification purposes, MUG is preferred, because the umbelliferyl radical emits fluorescence under UV stimulation, thus providing better sensitivity and easy measurement by fluorometry (Jefferson et al., "GUS Fusions: β Glucuronidase as a Sensitive and Versatile Gene Fusion Marker in Higher Plants," EMBO Journal 6:3901-3907 (1987), which is hereby incorporated by reference). Other suitable selection markers include, without limitation, markers encoding for antibiotic resistance, such as the nptll gene which confers kanamycin resistance (Fraley, et al., Proc. Natl. Acad. Sci. USA. 80:4803-4807 (1983), which is hereby incorporated by reference) and the dhfr gene, which confers resistance to methotrexate (Bourouis et al., EMBO J. 2:1099-1104 (1983), which is hereby incorporated by reference). A number of antibiotic-resistance markers are known in the art and others are continually being identified. Any known antibiotic- resistance marker can be used to transform and select transformed host cells in accordance with the present invention. Cells or tissues are grown on a selection medium containing an antibiotic, whereby generally only those transformants expressing the antibiotic resistance marker continue to grow. Similarly, enzymes providing for production of a compound identifiable by luminescence, such as luciferase, are useful. The selection marker employed will depend on the target species; for certain target species, different antibiotics, herbicide, or biosynthesis selection markers are preferred. Once a recombinant plant cell or tissue has been obtained, it is possible to regenerate a full-grown plant therefrom. Means for regeneration vary from species to species of plants, but generally a suspension of transformed protoplasts or a petri plate containing transformed explants is first provided. Callus tissue is formed and shoots may be induced from callus and subsequently rooted. Alternatively, embryo formation can be induced in the callus tissue. These embryos germinate as natural embryos to form plants. The culture media will generally contain various amino acids and hormones, such as auxin and cytokinins. It is also advantageous to add glutamic acid and proline to the medium, especially for such species as corn and alfalfa. Efficient regeneration will depend on the medium, on the genotype, and on the history of the culture. If these three variables are controlled, then regeneration is usually reproducible and repeatable. Plant regeneration from cultured protoplasts is described in Evans, et al., Handbook of Plant Cell Cultures. Vol. 1 : (MacMillan Publishing Co., New York, 1983); and Vasil I.R. (ed.), Cell Culture and Somatic Cell Genetics of Plants, Acad. Press, Orlando, Vol. I, 1984, and Vol. Ill (1986), which are hereby incorporated by reference. It is known that practically all plants can be regenerated from cultured cells or tissues, including but not limited to, all major species of rice, wheat, barley, rye, cotton, sunflower, peanut, corn, potato, sweet potato, bean, pea, chicory, lettuce, endive, cabbage, cauliflower, broccoli, turnip, radish, spinach, onion, garlic, eggplant, pepper, celery, carrot, squash, pumpkin, zucchini, cucumber, apple, pear, melon, strawberry, grape, raspberry, pineapple, soybean, tobacco, tomato, sorghum, sugarcane, and non-fruit bearing trees such as poplar, rubber, Paulownia, pine, and elm. After the DNA construct is stably incorporated in transgenic plants, it can be transferred to other plants by sexual crossing or by preparing cultivars. With respect to sexual crossing, any of a number of standard breeding techniques can be used depending upon the species to be crossed. Cultivars can be propagated in accord with common agricultural procedures known to those in the field. Alternatively, transgenic seeds are recovered from the transgenic plants. The seeds can then be planted in the soil and cultivated using conventional procedures to produce transgenic plants. Since loss of function (Sinl mutation) delays flowering, a gain of function, for example, by overexpression of Sinl gene, should promote early flowering. Accordingly, another aspect of the present invention relates to a method of increasing fertility in plants by transforming plants with the nucleic acid of the present invention. Fertility can be functionally (albeit simplistically) defined as the onset of reproductive maturity. By reducing the time from vegetative to floral stage in plants, overall breeding time can be reduced. Thus, the nucleic acid molecule of the present invention, as a regulator of flowering time, can be used to accelerate flowering in plants. This involves transforming plants with the nucleic acid of the present invention in an expression vector as described above, operably linked to an inducible promoter, such as the glucocorticoid inducible promoter. Transgenic plants in which an inducible promoter is present are treated with the suitable inducing agent (e.g., dexamethasone for the glucocorticoid inducible promoter) to induce flowering. Inducing SINI protein expression earlier in the development of the plant than normal accelerates early flowering, such that breeding time can be reduced. In addition, induction of flowering eliminates dependence upon external factors for flowering such as temperature and light (Coupland G., "Genetic and Environmental Control of Flowering Time in Arabidopsis," Mol. Gen. Genet. 242:81-89 (1995), which is hereby incorporated by reference), which are beyond the control of the average farmer. Early flowering plant lines may be especially useful for cultivation in short daylight environments. In another aspect of the present invention, the fecundity of plants can be increased by overexpression of the nucleic acid of the present invention, under control of a constitutive promoter. Fecundity relates to reproductive maturity in combination with the total number of seeds a mature plant can produce. Thus, decreasing the time to flowering with expression of the protein of the present invention is one factor of increased fecundity, as it increases time spent in the adult phase. The other factor, seed development, is also related to expression of the protein of the present invention, as this protein, when maternally expressed, appears to coordinate the expression of zygotic pattern formation in the embryo. In this aspect of the present invention, the nucleic acid of the present invention is inserted into an expression vector, as described above, operably linked to a constitutive promoter, for example, the CaMV35S promoter. Increased expression of the protein of the present invention, which functions both in the formation of seeds and in the mother plant in embryo formation, can result in increased fecundity. The present invention also relates to a method of decreasing fertility in plants. Because it may be commercially desirable to produce sterile female progeny, or plants with low expression of the protein of the present invention, transgenic plants can be produced in which the expression of this protein is down-regulated, or even entirely "switched off." In one aspect of the present invention, the nucleic acid of the present invention is replaced in the above-described expression vector by an antisense nucleic acid molecule which is complementary to the nucleic acid of the present invention or a fragment thereof. Antisense technology is commonplace to those skilled in the art, and the preparation of a vector and transgenic plants containing an antisense nucleic acid would be followed as described above. Transgenic plants are produced as described above, which exhibit a phenotype deficient in the nucleic acid of the present invention. In another aspect of the present invention, the silencing of the constitutive S7N7 gene involves the use of double-stranded RΝA ("dsR A") interference ("RΝAi"), a procedure which has recently been shown to induce potent and specific post-translational gene silencing in many organisms. See Bosher et al., "RΝA Interference: Genetic Wand and Genetic Watchdog," Nat Cell Biol 2:E31-6 (2000); Tavernarakis et al., "Heritable and Inducible Genetic Interference by Double-Stranded RNA encoded by Transgenes," Nat Genetics 24:180-3 (2000), which are hereby incorporated by reference. To construct transformation vectors that produce R As capable of duplex formation, two nucleic acid sequences according to the present invention, one in the sense and the other in the antisense orientation, are operably linked, and placed under the control of a strong viral promoter, such as CaMV 35S. The construct is introduced into the genome of Arabidopsis thaliana by Agrobacterium-mediated transformation (Chuang et al., "Specific and Heritable Genetic Interference by Double-Stranded RNA in Arabidopsis thaliana," Proc. Natl. Acad. Sci. USA 97:4985-90 (2000), which is hereby incorporated by reference), causing specific and heritable genetic interference, as evidenced by S7N7 deficient phenotype. In another aspect of the present invention, plant lines containing insertional mutations are produced, disrupting the endogenous S7N7 gene and thereby creating a SIΝ1 protein deficient plant with decreased fertility. This is accomplished by making use of well-characterized plant transposons such as the maize Activator ("Ac") and Dissociation ("Ds") family of transposable elements. The family is comprised of the autonomous element Ac, and the nonautonomous Ds element. Ds elements are not capable of autonomous transposition, but can be tr-j y-activated to transpose by Ac. Hehl et al., "Induced Transposition of Ds by a Stable Ac in Crosses of Transgenic Tobacco Plants," Mol. Gen. Genet. 217:53-59 (1989), which is hereby incorporated by reference. Thus, transposable elements, such as Ac/Ds of maize, can be operably linked to the nucleic acid of the present invention, transferred to other plants to generate a relatively small number if anchor plants (such as 500), and then to produce a much larger number of secondary insertional-mutant plant lines. The Ac/Ds system has been improved by the use of enhancer- and gene-trap plasmids (Sundaresan et al., "Patterns of Gene Action in Plant Development Revealed by Enhancer Trap and Gene Trap Transposable Elements," Genes & Develop. 9:1797-1810 (1995), which is hereby incorporated by reference), which allow disrupted genes with no phenotype to be detected by expression of a reporter gene (such as Gus). After insertion of the mutant genes, plants are screened using marker genes and appropriate crosses made to produce stable mutant plant lines. Sundaresan et al., "Patterns of Gene Action in Plant Development Revealed by Enhancer Trap and Gene Trap Transposable Elements," Genes & Develop. 9:1797-1810 (1995), which is hereby incorporated by reference. In another aspect of the present invention, the point mutations identified herein which result in S7N7 deficient phenotypes susl, sinl-1, and sinl- 2 can be prepared and used in the construct of the present invention to create transgenic plants and seeds carrying these point mutation alleles. The susl mutation is predicted to delete most of the functional domains of the SIΝ1 protein. The sinl-1 mutation produces a 415-proline to serine change in the protein; the sinl-2 produces a 431-isoleucine to lysine change within the C-terminus helicase domain. Molecular modeling indicates that these two mutations perturb the RΝA binding face of the DEHX box of the helicase C domain. Homozygous -?z 77-7 or sinl-2 mutation in Arabidopsis causes female sterility due to two separate phenotypic defects, and sinl mutants are late flowering. The allelic DΝA can be synthetically produced, according to methods known to those in the art, or by inserting the above disclosed point mutations in the nucleic acid of the present invention, thereby creating plants with decreased fertility and decreased/late flowering. In various aspects of the present invention the S7N7 gene is either up- or down-regulated, or turned off entirely. In order to ascertain the increase or decrease in SIΝ1 protein expression resulting from genetic manipulation, measurement of the production of the SIΝ1 protein in plant tissues is carried out following transformation. Western blot, or any similar method of protein detection is appropriate, using either polyclonal or monoclonal antibodies to the protein of the present invention. Polyclonal antibodies can be produced by procedures well-known to those skilled in the art, such as those disclosed in E. Harlow, et al, editors Antibodies: A Laboratory Manual (1988), which is hereby incorporated by reference. The preparation of monoclonal antibodies, as well as Fab and F(ab ')2 fragments, also useful in protein detection methods, can be produced by various commonly used methods, such as those described in Goding, Monoclonal Antibodies: Principles and Practice, pp. 98-118, New York: Academic Press (1983), which is hereby incorporated by reference. Although preferred embodiments have been depicted and described in detail herein, it will be apparent to those skilled in the relevant art that various modifications, additions, substitutions, and the like can be made without departing from the spirit of the invention and these are therefore considered to be within the scope of the invention as defined in the claims which follow.

Claims: WHAT IS CLAIMED: 1. An isolated nucleic acid molecule encoding a short integumentsl protein. 2. An isolated nucleic acid molecule according to claim 1 , wherein the nucleic acid molecule encodes a protein having an amino acid sequence of SEQ. ID. No. 2. 3. An isolated nucleic acid molecule according to claim 1 , wherein the nucleic acid has a nucleotide sequence of SEQ. ID. No. 1. 4. An antisense nucleic acid molecule encoding a nucleic acid sequence which is complementary to the DNA according to claim 1. 5. An isolated nucleic acid molecule according to claim 1, wherein the nucleic acid has a nucleotide sequence that is at least 55% similar to the nucleotide sequence of SEQ. ID. No. 1 by basic BLAST using default parameters analysis. 6. An isolated nucleic acid molecule according to claim 1 , wherein the nucleic acid hybridizes to the nucleotide sequence of SEQ. ID. No. 1 under stringent conditions characterized by a hybridization buffer comprising 0.9M sodium citrate buffer at a temperature of 45°C. 7. An expression vector comprising a transcriptional and translational regulatory DNA operably linked to a DNA molecule according to claim 1. 8. An expression vector according to claim 7, wherein the DNA molecule is in proper sense orientation and correct reading frame. 9. A host cell transduced with nucleic acid according to claim 10. A host cell according to claim 9, wherein the cell is selected from a group consisting of a bacterial cell, a virus, a yeast cell, and a plant cell. 11. A plant cell according to claim 10, wherein the nucleic acid molecule either 1) encodes an amino acid having SEQ. ID. No. 2, 2) has a nucleotide sequence of SEQ. ID. No. 1, 3) is at least 55% similar to the nucleotide sequence of SEQ. ID. No. 1 by basic BLAST using default parameters analysis, or 4) hybridizes to the nucleotide sequence of SEQ. ID. No. 1 under stringent conditions characterized by a hybridization buffer comprising 0.9M sodium citrate buffer at a temperature at a temperature of 45 °C. 12. A transgenic plant transduced with the nucleic acid according to claim 1. 13. A transgenic plant according to claim 12, wherein the nucleic acid molecule either 1) encodes an amino acid having SEQ. ID. No. 2, 2) has a nucleotide sequence of SEQ. ID. No. 1, 3) is at least 55% similar to the nucleotide sequence of SEQ. ID. No. 1 by basic BLAST using default parameters analysis, or 4) hybridizes to the nucleotide sequence of SEQ. ID. No. 1 under stringent conditions characterized by a hybridization buffer comprising 0.9M sodium citrate buffer at a temperature of 45°C. 14. A transgenic plant seed transduced with the nucleic acid according to claim 1. 15. A transgenic plant seed according to claim 14, wherein the nucleic acid molecule either 1) encodes an amino acid having SEQ. ID. No. 2, 2) has a nucleotide sequence of SEQ. ID. No. 1, 3) is at least 55% similar to the nucleotide sequence of SEQ. ID. No. 1 by basic BLAST using default parameters analysis, or 4) hybridizes to the nucleotide sequence of SEQ. ID. No. 1 under stringent conditions characterized by a hybridization buffer comprising 0.9M sodium citrate buffer at a temperature of 45°C. 16. An isolated short integumentsl protein. 17. An isolated protein according to claim 16, wherein the protein has an amino acid sequence of SEQ. ID. No. 2. 18. A method of regulating flowering in plants comprising: transducing a plant with a DNA molecule according to claim 1 under conditions effective to regulate flowering in the plant. 19. A method according to claim 18, wherein the nucleic acid molecule either 1) encodes an amino acid having SEQ. ID. No. 2, 2) has a nucleotide sequence of SEQ. ID. No. 1, 3) is at least 55% similar to the nucleotide sequence of SEQ. ID. No. 1 by basic BLAST using default parameters analysis, or 4) hybridizes to the nucleotide sequence of SEQ. ID. No. 1 under stringent conditions characterized by a hybridization buffer comprising 0.9M sodium citrate buffer at a temperature of 45°C. 20. A method of increasing fertility in plants comprising: transducing a plant with a DNA molecule according to claim 1 under conditions effective to increase fertility in the plant. 21. A method according to claim 20, wherein the nucleic acid molecule either 1) encodes an amino acid having SEQ. ID. No. 2, 2) has a nucleotide sequence of SEQ. ID. No. 1, 3) is at least 55% similar to the nucleotide sequence of SEQ. ID. No. 1 by basic BLAST using default parameters analysis, or 4) hybridizes to the nucleotide sequence of SEQ. ID. No. 1 under stringent conditions characterized by a hybridization buffer comprising 0.9M sodium citrate buffer at a temperature of 45°C. 22. A method of increasing fecundity of plants comprising: transducing a plant with a DNA molecule according to claim 1 under conditions effective to increase fecundity of the plant. 23. A method according to claim 22, wherein the nucleic acid molecule either 1) encodes an amino acid having SEQ. ID. No. 2, 2) has a nucleotide sequence of SEQ. ID. No. 1, 3) is at least 55% similar to the nucleotide sequence of SEQ. ID. No. 1 by basic BLAST using default parameters analysis, or 4) hybridizes to the nucleotide sequence of SEQ. ID. No. 1 under stringent conditions characterized by a hybridization buffer comprising 0.9M sodium citrate buffer at a temperature of 45°C. 24. A method of decreasing fertility in plants comprising: transducing a plant with a DNA molecule according to claim 1 mutated to cause disruption of the DNA molecule under conditions effective to decrease fertility. 25. A method according to claim 24 wherein a plant is transduced with a DNA molecule which encodes either 1) an antisense nucleic acid complementary to the nucleic acid molecule that encodes an amino acid having SEQ. ID. No. 2, 2) an antisense nucleic acid complementary to the nucleotide sequence of SEQ. ID. No. 1, 3) an antisense nucleic acid complementary to a nucleic acid molecule that is at least 55% similar to the nucleotide sequence of SEQ. ID. No. 1 by basic BLAST using default parameters analysis, or 4) hybridizes to the nucleotide sequence of SEQ. ID. No. 1 under stringent conditions characterized by a hybridization buffer comprising 0.9M sodium citrate buffer at a temperature of 45°C.

Inventors: GOLDEN TERESA ANN, RAY ANIMESH, GOLDEN, TERESA, ANN, RAY, ANIMESH
Applicants: UNIV ROCHESTER, UNIVERSITY OF ROCHESTER
Application year: 2000
Main classification: C12Q
IPC codes: C07K14, C12N9, C12N15